Santhera Enters Agreement with Columbia University to Investigate Additional Potential of Catena® in MELAS -- more

Santhera and NIH Collaborate To Evaluate Catena® in Primary Progressive Multiple Sclerosis -- more

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration -- more

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) -- more

AV-951 Demonstrates Prolonged Progression-Free Survival and Excellent Safety Profile in Patients with Advanced Kidney Cancer -- more

ExonHit and Institut Gustave Roussy Announce the Signing of a License Agreement for Novel Breast Cancer Diagnostic Assay -- more

Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF -- more

Ceres Yield Results: Energy Crop Benefits are Greatly Underestimated -- more

Elixir Pharmaceuticals Signs Option Agreement with a Major Pharmaceutical Company; Completes $12M Equity Financing -- more

ZettaCore Raises $21M; Panasonic Makes Strategic Investment -- more

VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round -- more

Forbes Magazine - VaxInnate: The Flu Vaccine Accelerator -- more

Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board -- more

Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory -- more

VaxInnate’s Seasonal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Study -- more

Asterand Announces Collaborative Agreement to Characterise Antibodies -- more

Astex Presents Key Data Differentiating its Phase I HSP90 inhibitor, AT13387, at the AACR Annual Meeting 2009 -- more

Astex Reports Positive Clinical Biomarker Data from its Phase I study on CDK Inhibitor AT7519 at the AACR Annual Meeting 2009 -- more

High-Yielding Switchgrass the Focus of Ceres and University of Georgia Researchers -- more

Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation -- more

Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 -- more

Astex Achieves Milestones in Drug Discovery Collaboration -- more

BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer -- more

CircuLite Demonstrates Long-Term Improvements and Hemodynamic Benefits with Synergy® Partial Circulatory Support in Chronic Heart Failure Patients -- more